![[ Visit Client Website ]](images/banner.gif)
Learning Objective 1: The learner will be able to understand the relationship between families perceived psychiatric stigma and drug attitude of schizophrenic patients
Learning Objective 2: The learner will be able to understand that family plays a significant role in the treatment process of patients
Methods: This study is a descriptive correlational research design. Convenience sample was used to collect one hundred ninety-seven schizophrenic patients and families pairs from outpatient department of medical institution in northern Taiwan. Research instrument was including three parts: (1) demographic data of subjects and their families; (2) the Perceived Psychiatric Stigma Scale was used to measure families′ perceived psychiatric stigma; (3) the Chinese Version of The Drug Attitude Inventory (DAI) was used to measure schizophrenic patients’ attitudes toward medication. SPSS version 17.0 was conducted to analyze the data. Inferential statistics includes Pearson’s correlation, t-test, one-way ANOVA.
Results: The research result shows that the average score of Families’ perceived psychiatric stigma was 62.03. The higher the family’s education level is, the lower the total score of perceived psychiatric stigma is. Moreover, families who are unemployed have higher score in perceived psychiatric stigma than employed family. The family of subjects with more hospitalization scores higher in sum of self-deprecation subscale of the Perceived Psychiatric Stigma Scale. 2. The average scale score for Drug Attitude Inventory was 15.9. The longer the subjects’ years of education are, the higher the sum- score of drug attitude is. Participants experiencing side effects were more report negative to dysphoric response of drug attitude. 3. There was a negative correlation between family perceived psychiatric stigma and drug attitudes.
Conclusion: This research can provide reference for psychiatric professionals and to reinforce medical staffs’ attention on stigma of mental illness so that patients’ drug attitude can be improved and better care quality can be provided.